Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA

  title={Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA},
  author={Mar{\'i}a A. Blasco and Han-Woong Lee and Manoor Prakash Hande and Enrique Samper and Peter M. Lansdorp and Ronald A. DePinho and Carol W. Greider},

Figures and Tables from this paper

Severe growth defect in mouse cells lacking the telomerase RNA component

Accompanying the continual telomere shortening, the growth rate of Terc-deficient ES cells was gradually reduced after more than 300 divisions, and then cell growth virtually stopped, showing that telomerase-dependent telomeres maintenance is critical for the growth of mammalian cells.

Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis

It is shown that late-generation Terc−/− mice, which have short telomeres and are telomerase-deficient, are resistant to tumour development in multi-stage skin carcinogenesis, and predicted that an anti-telomerase–based tumour therapy may be effective in epithelial tumours.

Short Telomeres Initiate Telomere Recombination in Primary and Tumor Cells

Human tumors that lack telomerase maintain telomeres by alternative lengthening mechanisms. Tumors can also form in telomerase-deficient mice; however, the genetic mechanism responsible for tumor

Telomere Maintenance in Telomerase-Deficient Mouse Embryonic Stem Cells: Characterization of an Amplified Telomeric DNA

Characterization of the telomersic structures in one of the survivor mTER−/− cell lines showed amplification of the same tandem arrays of telomeric and nontelomeric sequences at most of the chromosome ends, which implicatescis/trans amplification as one mechanism for the telomerase-independent maintenance of telomeres in mammalian cells.

Inhibition of telomerase limits the growth of human cancer cells

It is shown here that expression of a mutant catalytic subunit of human telomerase results in complete inhibition of telomer enzyme activity, reduction in telomere length and death of tumor cells, validating human telomersase reverse transcriptase as an important target for the development of anti-neoplastic therapies.

Telomeres, telomerase, and myc. An update.

Dysfunctional telomeres promote genomic instability and metastasis in the absence of telomerase activity in oncogene induced mammary cancer

It is concluded that short telomeres promote metastasis in the absence of telomerase activity in neu oncogene driven mammary tumors.



Telomerase activation in mouse mammary tumors: lack of detectable telomere shortening and evidence for regulation of telomerase RNA with cell proliferation

The data suggest that the mechanism of telomerase activation in mouse mammary tumors is not linked to global loss of telomere function but involves multiple regulatory events including upregulation of telomersase RNA in proliferating cells.

Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity.

The results suggest that chromosomes with short (TTAGGG)n tracts are recombinogenic, critically shortened telomeres may be incompatible with cell proliferation and stabilization of telomere length by telomerase may be required for immortalization.

Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis

Results clearly demonstrate telomersase is activated in late stages of tumour progression, and show for the first time that the initial up regulation of telomerase RNA is an early event, concurrent with the hyperproliferation elicited by viral oncogenes.

Telomerase activity in normal and malignant murine tissues.

Telomerase activity during mammary tumorigenesis in transgenic mice overexpressing the neu gene was elevated in tumors versus normal tissues and was enhanced by short-term culturing of normal cells.

The RNA component of human telomerase

Human cell lines that expressed hTR mutated in the template region generated the predicted mutant telomerase activity, and cells transfected with an antisense hTR lost telomeric DNA and began to die after 23 to 26 doublings.

Developmental and tissue-specific regulation of mouse telomerase and telomere length.

  • K. ProwseC. Greider
  • Biology
    Proceedings of the National Academy of Sciences of the United States of America
  • 1995
It is suggested that there is tissue-specific regulation of mouse telomerase during development and aging in vivo, and most mouse tissues had active telomerases, compared to human tissues, which may reflect the ease of immortalization of primary mouse cells relative to human cells in culture.

Telomere elongation in immortal human cells without detectable telomerase activity.

It is suggested that the presence of lengthened or stabilized telomeres is necessary for immortalization, and that this may be achieved either by the reactivation of telomerase or by a novel and as yet unidentified mechanism.

Functional characterization and developmental regulation of mouse telomerase RNA

The shorter template regions of the mouse and other rodent telomerase RNAs could account for the shorter distribution of products (processivity) generated by the mouse enzyme relative to the human telomersase.

Specific association of human telomerase activity with immortal cells and cancer.

Synthesis of DNA at chromosome ends by telomerase may be necessary for indefinite proliferation of human cells. A highly sensitive assay for measuring telomerase activity was developed. In cultured

Increased telomerase activity in mouse skin premalignant progression.

It appears that the progressive increase in telomerase activity is associated with the increased level of genomic instability and the phenotypic progression of these premalignant tumors.